Skip to content

Safety and Efficacy Study of the Treatment of Humerus Fractures

CE Marking Study of the IlluminOss Photodynamic Bone Stabilization System for the Treatment of Humerus Fractures

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02394080
Enrollment
44
Registered
2015-03-20
Start date
2015-02-01
Completion date
2018-01-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Humerus Fractures

Brief summary

The purpose of this study is to collect safety and performance data on the use of the Photodynamic Bone Stabilization System (PBSS) when used to provide stabilization and alignment for the treatment of acute humerus fractures.

Interventions

Treatment of acute humerus fractures

Sponsors

IlluminOss Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Fracture-Specific Inclusion Criteria 1. Radiograph-confirmed diagnosis of acute, single isolated fracture of the humerus. AO classification 11A2, 11A3 and 11B1, 11B2 and 12A1, 12A2, 12A3 and 12B1, 12B2 (The Netherlands); AO Classification 11A1, 11A2, 11A3 and 11B1, 11B2 and 12A1, 12A2, 12A3 and 12B1, 12B2 and 13A1, 13A2 and 13B1, 13B2 (Germany). 2. Fracture is closed, Gustilo Type I or II. General Inclusion Criteria 3. Skeletally mature men and women, 50 years of age or older (The Netherlands only) or 61 years of age or older (Germany only) at time of index injury. 4. a) Female patients of child bearing potential agree to use double barrier method of contraception (The Netherlands only) b) Female patients of non-child bearing potential must meet one of the following criteria (The Netherlands only): * Postmenopausal for at least 1 year, or * Documented oophorectomy or hysterectomy, or * Surgically sterile 5. Willing and able to understand and sign the informed consent. Fracture-Specific

Exclusion criteria

1. Index treatment is greater than 28 days (The Netherlands only) or 14 days (Germany only) post fracture 2. Open fractures with severe contamination. 3. Extremely comminuted fractures where insufficient holding power of the balloon on the intramedullary canal is probable. 4. Marked bone loss or bone resorption patients, who due to a prior delayed union or non-union of the bones or other illnesses, may not be able to have their fracture adequately reduced prior to placement of the IlluminOss-device. This could leave bone void spaces that would preclude the device from maintaining alignment of the fractured bone. 5. Previous fracture of affected limb. General

Design outcomes

Primary

MeasureTime frameDescription
Normal Radiographic Fracture Healing180 daysTwo of four cortices or two of four views demonstrating bridging on standard radiographs

Secondary

MeasureTime frameDescription
Evaluation of Complete Radiographic Healing180 and 360 daysThree of four cortices or three of four views demonstrating bridging, with dissolution of the majority (greater than or equal to 75% on orthogonal views) of fracture lines
Evaluation of Normal Radiographic Healing360 daysTwo of four cortices or two of four views demonstrating bridging on standard radiographs
Summary of Pain VAS180 and 360 daysChange from baseline of pain visual analog score (VAS). Participants indicate their pain level by marking a point along a continuous horizontal line anchored by "No Pain" and "Severe Pain. Total score range: 0 to 100 units on a scale 0 = No pain 100 = Severe pain. Lower scores represent a better outcome (less pain), while higher scores represent a worse outcome (greater pain)
Summary of DASH Score180 and 360 daysChange from baseline of disability of the arm shoulder and hand (DASH) score. DASH Disability/Symptom Total Score range: 0 to 100 units on a scale 0 = No disability/symptoms; 100 = Most severe disability/symptoms. Each item is scored on a 5-point Likert scale. Lower scores represent a better outcome (less disability and fewer symptoms), while higher scores represent a worse outcome (greater disability and more severe symptoms)
Summary of Constant Shoulder Score180 and 360 daysChange from baseline of constant shoulder score. Total Constant Score range: 0 to 100 units on a scale 0 = Worst shoulder function; 100 = Best shoulder function. The total Constant Score is calculated by summing the four subscale scores for a maximum of 100 points. Higher scores represent a better outcome (improved shoulder function and less pain), while lower scores represent a worse outcome (greater disability and impaired shoulder function).
Summary of Pain on Palpation180 and 360 daysPain at Palpation (yes/no), grade and clinical significance. Grade: mild, moderate, severe
Summary of Return to Pre-Fracture Mobility180 and 360 daysSummary of subjects who returned to pre-fracture mobility (yes/no)
Summary of Range of Motion180 and 360 daysSummary of range of motion (active and passive) for affected and unaffected arm, for abduction, flexion, extension and lateral and medial rotation.
Summary of Disability Status180 and 360 daysDisability status as determined by the investigator

Countries

Germany, Netherlands

Participant flow

Recruitment details

44 patients signed the informed consent form. 44 is the modified intent to treat group, 33 is the intent to treat group

Baseline characteristics

Characteristic
Age, Continuous76.6 years
STANDARD_DEVIATION 10.16
AO Classification
02-A3
0 Participants
AO Classification
11-A1
1 Participants
AO Classification
11-A2
8 Participants
AO Classification
11-A3
2 Participants
AO Classification
11-B1
9 Participants
AO Classification
11-B2
13 Participants
AO Classification
11-C2
0 Participants
Gustilo Grading of Soft Tissue
Closed
26 Participants
Gustilo Grading of Soft Tissue
Type I
7 Participants
Location
Diaphyseal
1 Participants
Location
Distal
0 Participants
Location
Proximal
32 Participants
Location of Target Fracture
Left Humerus
23 Participants
Location of Target Fracture
Right Humerus
10 Participants
Neer's Fracture Grading
2-part
11 Participants
Neer's Fracture Grading
3-part
14 Participants
Neer's Fracture Grading
4-part
4 Participants
Neer's Fracture Grading
N/A
4 Participants
Region of Enrollment
Germany
11 Participants
Region of Enrollment
Netherlands
22 Participants
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
8 Participants
Traumatic Injury Specify
Other
10 Participants
Traumatic Injury Specify
Sports Injury
2 Participants
Type of Injury
Non-Traumatic
1 Participants
Type of Injury
Non-Traumatic, low energy fall
20 Participants
Type of Injury
Traumatic
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
4 / 33
other
Total, other adverse events
14 / 33
serious
Total, serious adverse events
14 / 33

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026